Autoimmune encephalitis study
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study is for people with autoimmune encephalitis, a condition where the immune system attacks the brain. It aims to collect information about this disease to learn more about it and how to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been recently diagnosed with autoimmune encephalitis.
- Your diagnosis must meet certain specific medical criteria set by experts.
- If you have epilepsy caused by the encephalitis, you may also join.
- You or your legal representative must agree to take part in the study and sign a form.
- There are no other requirements to not be in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.
This study looks at how autoimmune encephalitis affects brain metabolism using a special PET scan. It aims to better understand the condition in people who were recently diagnosed.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This study tests whether an experimental treatment using tiny particles from stem cells (called exosomes) given through the nose can help people with autoimmune encephalitis. It is for adults who were recently diagnosed and have specific antibodies.
This observational study follows people with various immune-related neurological conditions, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It aims to better understand these diseases and their progression over time.
Hear when a new Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.